Evidence map›Paper›PMID 39382693›Full record

ArticleIntensive care medicine2024

Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectories.

Sivasubramanium V Bhavani, Alexandra Spicer, Pratik Sinha, Albahi Malik, Carlos Lopez-Espina, Lee Schmalz, Gregory L Watson, Akhil Bhargava, Shah Khan, Dennys Urdiales and 16 more

Abstract read
In one paragraph

Article in Intensive care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Sivasubramanium V BhavaniSchool of Medicine, Emory University, Atlanta, GA, USA. sivasubramanium.bhavani@emory.edu.ORCID 0000-0002-9640-6720
Alexandra SpicerDepartment of Medicine, University of Wisconsin, Madison, WI, USA.
Pratik SinhaSchool of Medicine, Washington University, St. Louis, MO, USA.
Albahi MalikSchool of Medicine, Emory University, Atlanta, GA, USA.
Carlos Lopez-EspinaPrenosis, Inc., Chicago, IL, USA.
Lee SchmalzPrenosis, Inc., Chicago, IL, USA.
Gregory L WatsonPrenosis, Inc., Chicago, IL, USA.
Akhil BhargavaPrenosis, Inc., Chicago, IL, USA.
Shah KhanPrenosis, Inc., Chicago, IL, USA.
Dennys UrdialesPrenosis, Inc., Chicago, IL, USA.
Lincoln UpdikePrenosis, Inc., Chicago, IL, USA.
Alon DaganDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Hugo DavilaBeaumont Health System, Royal Oak, MI, USA.
Carmen DemarcoBeaumont Health System, Royal Oak, MI, USA.
Neil EvansDavis School of Medicine, University of California, Sacramento, CA, USA.
Falgun GosaiOSF Saint Francis Medical Center, Peoria, IL, USA.
Karthik IyerMercy Hospital, Jefferson, MO, USA.
Niko KurtzmanSchool of Medicine, Emory University, Atlanta, GA, USA.
Ashok V PalagiriMercy Hospital, Jefferson, MO, USA.
Matthew SimsBeaumont Health System, Royal Oak, MI, USA.
Scott SmithBeaumont Health System, Royal Oak, MI, USA.
Anwaruddin SyedOSF Saint Francis Medical Center, Peoria, IL, USA.
Deesha SarmaDepartment of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Bobby ReddyPrenosis, Inc., Chicago, IL, USA.
Philip A VerhoefUniversity of Hawaii John A. Burns School of Medicine, Honolulu, HI, USA.
Matthew M ChurpekDepartment of Medicine, University of Wisconsin, Madison, WI, USA.

Funding

Use of Time Series Biomarker and Clinical Data to Construct a Time Trajectory Host Response MapR44GM149095 · NIGMS · PRENOSIS, INC. · PI REDDY, BOBBY · 2023 to 2024
$2.5M
Precision Medicine in Sepsis with Critical IllnessR35GM142992 · NIGMS · WASHINGTON UNIVERSITY · PI Pratik Sinha · 2021 to 2026
$2.4M
Sepsis Early Prediction and Subphenotype Illumination Study (SEPSIS)R35GM145330 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Matthew Michael Churpek · 2022 to 2026
$1.9M
Sepsis Early Prediction and Subphenotype Illumination Study (SEPSIS)R01GM123193 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI CHURPEK, MATTHEW MICHAEL · 2017 to 2021
$1.9M
Identification of Precision Sepsis Subphenotypes Using Vital Sign TrajectoriesK23GM144867 · NIGMS · EMORY UNIVERSITY · PI BHAVANI, SIVASUBRAMANIUM · 2021 to 2025
$890k
NIGMS NIH HHS K23 GM144867NIGMS NIH HHS R01 GM123193NIGMS NIH HHS R35 GM142992NIGMS NIH HHS R35 GM145330NIGMS NIH HHS R44 GM149095
6 · The paper itself

Abstract

purposeSepsis is a heterogeneous syndrome. Identification of sepsis subphenotypes with distinct immune profiles could lead to targeted therapies. This study investigates the immune profiles of patients with sepsis following distinct body temperature patterns (i.e., temperature trajectory subphenotypes).

methodsHospitalized patients from four hospitals between 2018 and 2022 with suspicion of infection were included. A previously validated temperature trajectory algorithm was used to classify study patients into temperature trajectory subphenotypes. Microbiological profiles, clinical outcomes, and levels of 31 biomarkers were compared between these subphenotypes.

resultsThe 3576 study patients were classified into four temperature trajectory subphenotypes: hyperthermic slow resolvers (N = 563, 16%), hyperthermic fast resolvers (N = 805, 23%), normothermic (N = 1693, 47%), hypothermic (N = 515, 14%). The mortality rate was significantly different between subphenotypes, with the highest rate in hypothermics (14.2%), followed by hyperthermic slow resolvers 6%, normothermic 5.5%, and lowest in hyperthermic fast resolvers 3.6% (p < 0.001). After multiple testing correction for the 31 biomarkers tested, 20 biomarkers remained significantly different between temperature trajectories: angiopoietin-1 (Ang-1), C-reactive protein (CRP), feline McDonough sarcoma-like tyrosine kinase 3 ligand (Flt-3l), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin (IL)-15, IL-1 receptor antagonist (RA), IL-2, IL-6, IL-7, interferon gamma-induced protein 10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), human macrophage inflammatory protein 3 alpha (MIP-3a), neutrophil gelatinase-associated lipocalin (NGAL), pentraxin-3, thrombomodulin, tissue factor, soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), and vascular cellular adhesion molecule-1 (vCAM-1).The hyperthermic fast and slow resolvers had the highest levels of most pro- and anti-inflammatory cytokines. Hypothermics had suppressed levels of most cytokines but the highest levels of several coagulation markers (Ang-1, thrombomodulin, tissue factor).

conclusionSepsis subphenotypes identified using the universally available measurement of body temperature had distinct immune profiles. Hypothermic patients, who had the highest mortality rate, also had the lowest levels of most pro- and anti-inflammatory cytokines.

Indexed as

BiomarkersBody TemperatureSepsisAgedC-Reactive ProteinFemaleHumansMaleMiddle AgedPhenotypeBiomarkersC-Reactive ProteinArtificial intelligenceFeverPhenotypesSepsisTemperature

Identifiers

PMID39382693
PMCPMC12674214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.